Listonstreetpulse.com announces that Opko Health Inc.’s (NYSE: OPK) subsidiary, Opko Pharmaceuticals LLC, bought Arrayit Corporation’s (OTC: ARYC) patented and proprietary NanoPrint™ LM60 Microarray Printer and One-Year Service Warranty for $146,000.
Arrayit’s NanoPrint™ instruments empower pharmaceutical companies to manufacture microarrays containing microscopic collections of genes and proteins that permit the accurate and highly automated analysis of the human genome and proteome. Arrayit’s microarray technology allows the company’s pharmaceutical clients to develop more efficacious medicines. The technology also helps in identifying biomarkers for treatable and curable human diseases.
Opko is focused on the discovery, development, and commercialization of proprietary technologies. The company was founded in 2007 by legendary American entrepreneur Dr. Phillip Frost, who currently serves as the company’s Chairman and CEO. Dr. Frost previously founded Ivax Corporation, which was acquired by Teva Pharmaceuticals Industries in 2006 for $7.4 billion.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
